Domenici, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 11.271
AS - Asia 3.548
EU - Europa 2.438
SA - Sud America 761
Continente sconosciuto - Info sul continente non disponibili 481
AF - Africa 71
OC - Oceania 19
Totale 18.589
Nazione #
US - Stati Uniti d'America 11.120
SG - Singapore 1.562
VN - Vietnam 672
BR - Brasile 609
CN - Cina 604
IT - Italia 594
RU - Federazione Russa 308
SE - Svezia 274
FI - Finlandia 222
GB - Regno Unito 198
DE - Germania 165
FR - Francia 165
LV - Lettonia 145
HK - Hong Kong 114
KR - Corea 111
BG - Bulgaria 93
UA - Ucraina 82
IN - India 80
BD - Bangladesh 71
CA - Canada 67
ID - Indonesia 63
TR - Turchia 43
IQ - Iraq 40
MX - Messico 40
AR - Argentina 39
JP - Giappone 32
EC - Ecuador 30
NL - Olanda 28
AT - Austria 26
CO - Colombia 24
ZA - Sudafrica 24
CL - Cile 20
PL - Polonia 20
JO - Giordania 19
PK - Pakistan 18
SA - Arabia Saudita 18
PH - Filippine 17
VE - Venezuela 15
ES - Italia 14
AU - Australia 13
CH - Svizzera 12
CZ - Repubblica Ceca 12
UZ - Uzbekistan 12
IE - Irlanda 11
RO - Romania 11
CR - Costa Rica 10
DK - Danimarca 10
KE - Kenya 9
AE - Emirati Arabi Uniti 8
BE - Belgio 8
PY - Paraguay 8
TN - Tunisia 8
ET - Etiopia 7
IL - Israele 7
MY - Malesia 7
NP - Nepal 7
TT - Trinidad e Tobago 7
AZ - Azerbaigian 6
EG - Egitto 6
JM - Giamaica 6
MA - Marocco 6
PE - Perù 6
PT - Portogallo 6
UY - Uruguay 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DZ - Algeria 5
LT - Lituania 5
TH - Thailandia 5
AL - Albania 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
RS - Serbia 4
DO - Repubblica Dominicana 3
GA - Gabon 3
GR - Grecia 3
HN - Honduras 3
KW - Kuwait 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
IR - Iran 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
Totale 18.098
Città #
Fairfield 1.384
Ashburn 1.044
Singapore 973
Chandler 888
Woodbridge 667
Houston 538
Seattle 528
Wilmington 481
Cambridge 471
San Jose 412
Columbus 357
Santa Clara 333
Dallas 276
Jacksonville 265
Princeton 254
Ann Arbor 241
Council Bluffs 231
Ho Chi Minh City 171
San Mateo 151
Hanoi 150
Riga 145
Moscow 143
New York 141
Lauterbourg 126
The Dalles 126
Trento 112
Dearborn 111
Seoul 107
Hong Kong 102
Phoenix 102
Los Angeles 97
Beijing 94
Helsinki 92
Sofia 92
San Diego 69
Chicago 57
London 55
Boardman 53
Como 53
Milan 48
Munich 48
São Paulo 48
Fremont 45
Jakarta 45
Dong Ket 41
Da Nang 39
Orem 38
San Paolo di Civitate 37
Buffalo 36
Frankfurt am Main 30
Austin 29
Bassano del Grappa 29
Tokyo 28
Brooklyn 27
Des Moines 27
Izmir 27
Nuremberg 27
Redondo Beach 27
Guangzhou 26
Norwalk 26
Lappeenranta 25
Hefei 23
Rome 23
Haiphong 20
Chennai 19
Rio de Janeiro 19
Warsaw 19
Altamura 18
Montreal 18
Washington 18
Bologna 17
Shanghai 17
Belo Horizonte 16
Kilburn 15
Salt Lake City 15
San Francisco 15
Stockholm 15
Denver 14
Kunming 14
Round Rock 14
Manchester 13
Quito 13
Toronto 13
Baghdad 12
Johannesburg 12
Atlanta 11
Falkenstein 11
Nanjing 11
Paris 11
Porto Alegre 11
Turku 11
Vienna 11
Amsterdam 10
Charlotte 10
Chiswick 10
Miano 10
Poplar 10
Santiago 10
Tashkent 10
Thái Bình 10
Totale 12.994
Nome #
Networks of blood proteins in the neuroimmunology of schizophrenia 373
Depression-Associated Gene Negr1-Fgfr2 Pathway Is Altered by Antidepressant Treatment 255
The Italian autism network (ITAN): A resource for molecular genetics and biomarker investigations 251
Landscape of Conditional eQTL in Dorsolateral Prefrontal Cortex and Co-localization with Schizophrenia GWAS 234
Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies 227
MLL4-associated condensates counterbalance Polycomb-mediated nuclear mechanical stress in Kabuki syndrome 222
A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome 214
Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation 212
Characterization of divIVA and other genes located in the chromosomal region downstream of the dcw cluster in Streptococcus pneumoniae 210
Gene expression imputation across multiple brain regions provides insights into schizophrenia risk 196
Association of Whole-Genome and NETRIN1 Signaling Pathway–Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank 191
Transcriptome signatures from discordant sibling pairs reveal changes in peripheral blood immune cell composition in Autism Spectrum Disorder 187
Transcriptome analysis of the zebrafish atoh7-/- Mutant, lakritz, highlights Atoh7-dependent genetic networks with potential implications for human eye diseases 185
BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders 184
The person-to-person transmission landscape of the gut and oral microbiomes 183
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 174
Gene expression elucidates functional impact of polygenic risk for schizophrenia 172
Advances in multidisciplinary and cross-species approaches to examine the neurobiology of psychiatric disorders 168
Backbone Assignment of Gyrase-B P24 Fragment and Its Interactions with the Inhibitor GR122222 168
Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation 168
The interplay between oxidative stress and inflammation supports autistic-related behaviors in Cntnap2 knockout mice 164
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes 164
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. 163
Age at first birth in women is genetically associated with increased risk of schizophrenia 162
Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis 161
Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression 160
Biomarkers for Antipsychotic Therapies 159
Characterization of divIVA and other genes located in the chromosomal region downstream of the dcw cluster in Streptococcus pneumoniae 158
Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium 156
Genome-wide Regional Heritability Mapping Identifies a Locus Within the TOX2 Gene Associated With Major Depressive Disorder 152
Schizophrenia risk from complex variation of complement component 4 151
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects 150
Biological insights from 108 schizophrenia-associated genetic loci 148
Schizophrenia genetics comes to translation 147
Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia 147
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression 144
A new integrated statistical approach to the diagnostic use of two-dimensional maps 143
Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses 142
Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ions 141
Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness 141
Hair Cortisol in Twins: Heritability and Genetic Overlap with Psychological Variables and Stress-System Genes 139
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores 139
An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype 138
Estimation of Genetic Correlation via Linkage Disequilibrium Score Regression and Genomic Restricted Maximum Likelihood 138
Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia 138
Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: Hemispheric asymmetry and reversal by fluoxetine treatment 137
Peripheral biomarkers for depression by plasma and serum proteomics 137
Contribution of Common Genetic Variants to Antidepressant Response 135
A retrospective analysis of the COVID-19 pandemic evolution in Italy 135
Genetic association of major depression with a typical features and obesity-related immunometabolic dysregulations 132
Albumin 131
Genetic influences on schizophrenia and subcortical brain volumes: Large-scale proof of concept 131
Regulation of cytoskeleton machinery, neurogenesis and energy metabolism pathways in a rat gene-environment model of depression revealed by proteomic analysis. 131
Identification of common genetic risk variants for autism spectrum disorder 131
Nortriptyline influences protein pathways involved in carbohydrate metabolism and actin-related processes in a rat gene-environment model of depression 130
Expression Profiling of a Genetic Animal Model of Depression Reveals Novel Molecular Pathways Underlying Depressive-Like Behaviours 130
CIRCULAR-DICHROISM DETECTION IN HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - EVALUATION OF THE ANISOTROPY FACTOR 130
A Follow-Up Case-Control Association Study of Tractable (Druggable) Genes in Recurrent Major Depression 130
Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats 129
Proteome effects of antipsychotic drugs: Learning from preclinical models 129
Chronic psychosocial stress alters NPY system: Different effects in rat and tree shrew 129
MOUSSE: Multi-omics using subject-specific signatures 129
No Reliable Association between Runs of Homozygosity and Schizophrenia in a Well-Powered Replication Study 127
Copy number variants and therapeutic response to antidepressant medication in major depressive disorder 127
LD score regression distinguishes confounding from polygenicity in genome-wide association studies 127
A miR-137–Related Biological Pathway of Risk for Schizophrenia Is Associated With Human Brain Emotion Processing 126
The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder 126
An age-dependent mathematical model of neurofilament trafficking in healthy conditions 126
A role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress 125
Microarray analysis of cultured rat hippocampal neurons treated with brain derived neurotrophic factor 123
Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts 123
A large scale depression case-control study and its impact on drug discovery & development 122
Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls 122
Proteome analysis of rat polymorphonuclear leukocytes: A two-dimensional electrophoresis/mass spectrometry approach 119
Functional proteomic analysis of an animal model of depression combining genetic vulnerability and environmental stress 119
Proteomic analysis of rat hippocampus after repeated psychosocial stress 118
Reversible and covalent binding of drugs to human serum albumin: Methodological approaches and physiological relevance 118
A scintillation proximity assay amenable for screening and characterization of DNA gyrase B subunit inhibitors 118
Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases 118
Natural SINEUP RNAs in Autism Spectrum Disorders: RAB11B-AS1 Dysregulation in a Neuronal CHD8 Suppression Model Leads to RAB11B Protein Increase 118
Genetic Susceptibility for Bipolar Disorder and Response to Antidepressants in Major Depressive Disorder 116
Phage-display and correlated mutations identify an essential region of subdomain 1C involved in homodimerization of Escherichia coli FtsA 116
CHIRAL 1,4-BENZODIAZEPIN-2-ONES - RELATIONSHIP BETWEEN STEREOCHEMISTRY AND PHARMACOLOGICAL ACTIVITY 114
Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists 114
Global analysis of transcription kinetics during competence development in Streptococcus pneumoniae using high density DNA arrays 114
Exploratory analysis of L1 retrotransposons expression in autism 113
A mechanistic model of pure and lipidic α-synuclein aggregation for advancing Parkinson’s therapies 113
Drug binding to human serum albumin: Abridged review of results obtained with high-performance liquid chromatography and circular dichroism 113
Discovering genetic polymorphism associated with gene expression levels across the whole genome 113
IMMOBILIZED SERUM-ALBUMIN - RAPID HPLC PROBE OF STEREOSELECTIVE PROTEIN-BINDING INTERACTIONS 112
STEREOCHEMICAL FEATURES OF 1,4-BENZODIAZEPIN-2-ONES BOUND TO HUMAN SERUM-ALBUMIN - DIFFERENCE CD AND UV STUDIES 112
USE OF A HUMAN SERUM ALBUMIN-BASED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY CHIRAL STATIONARY PHASE FOR THE INVESTIGATION OF PROTEIN-BINDING - DETECTION OF THE ALLOSTERIC INTERACTION BETWEEN WARFARIN AND BENZODIAZEPINE BINDING-SITES 112
Functional proteomic analysis of an animal model of depression combining genetic vulnerability and environmental stress 112
A pediatric quantitative systems pharmacology model of neurofilament trafficking in spinal muscular atrophy treated with the antisense oligonucleotide nusinersen 111
Proteomic analysis of rat cortical neurons after fluoxetine treatment 111
Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections 110
Development of a high-throughput scintillation proximity assay for the identification of C-domain translational initiation factor 2 inhibitors 110
Identification of altered dipeptidyl-peptidase activities as potential biomarkers for unipolar depression. 110
Microarray analysis of cultured human brain aggregates following cortisol exposure: Implications for cellular functions relevant to mood disorders 110
Proteome effects of antidepressant medications 109
Totale 14.602
Categoria #
all - tutte 83.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.645
Totale 88.562


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.207 0 0 19 48 56 80 52 278 83 159 147 285
2022/20231.837 249 294 37 221 153 295 30 169 228 18 95 48
2023/2024678 45 73 65 14 64 113 39 27 6 57 83 92
2024/20252.539 16 19 89 650 125 315 71 104 264 444 187 255
2025/20265.421 316 144 682 974 479 349 942 169 487 481 189 209
2026/2027876 148 330 398 0 0 0 0 0 0 0 0 0
Totale 18.589